September 2026

National Institute of Science Education and Research (NISER), Bhubaneswar is an autonomous research institute under the Department of Atomic Energy, Government of India, affiliated with Homi Bhabha National Institute (HBNI). Established in 2007, NISER focuses on advanced education and research in fundamental sciences, including biology, chemistry, mathematics and physics, along with interdisciplinary areas. The institute offers integrated and doctoral programmes and conducts frontier research through its specialized schools and research facilities.

For the past 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle.

Are you ready to play a central role in how Novo Nordisk governs pharmacovigilance excellence across the globe? This is your chance to help shape the systems, processes and training frameworks that keep our pharmacovigilance operations compliant, inspection-ready and continuously improving – directly supporting patient safety at scale.

Post: PV Process Excellence Specialist

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing.

Strides Pharma Science Limited is a Bengaluru-headquartered global pharmaceutical company established in 1990. The company develops and manufactures IP-led niche and complex generic medicines and serves regulated and emerging markets across 100+ countries. Strides has capabilities across multiple dosage forms, including tablets, capsules, sachets, liquids, nasal sprays, topical products and other specialized formulations. Its R&D activities focus on complex generics, novel drug-delivery systems and differentiated formulations.

Walk-in Recruitment Drive @ Bengaluru

Swiss Parenterals Limited is an Ahmedabad-based pharmaceutical company specializing in the development and manufacturing of generic and specialty pharmaceutical products, particularly sterile injectables. The company has more than 25 years of experience and operates as a dossier-driven pharmaceutical business serving international markets.  Swiss focuses on sterile injectable products, including liquid vials, lyophilized products and other complex dosage forms.

H&H Healthcare and Cosmetics Pvt. Ltd. is a B2B healthcare and contract development and manufacturing organization (CDMO) based in Madhya Pradesh, with its manufacturing facility located at Smart Industrial Park, Pithampur. The company develops and manufactures nutraceutical, herbal, Ayurvedic and healthcare products, with capabilities covering R&D, formulation development, manufacturing, packaging and private-label solutions.

Kusum Group of Companies is a global pharmaceutical group headquartered in New Delhi, India, with manufacturing and R&D operations across multiple countries. Through Kusum Healthcare, the group manufactures a range of pharmaceutical formulations including tablets, pellets, topical products and other dosage forms at its facilities in India. The group focuses on providing high-quality, affordable medicines for international markets and operates manufacturing facilities that follow international GMP and quality standards.

The United States has included India, China and Pakistan among 23 countries designated as major drug transit or major illicit drug-producing countries for fiscal year 2027. The designation was submitted to the U.S. Congress on September 15, 2026, as part of the annual U.S. “Major’s List,” which identifies countries considered significant sources or transit points for illicit drugs entering the United States.